Bioventus Inc - Class A — Cash Flow (NASDAQ:BVS) | MetaTrader

Open full chart

Financials

Overview 声明 Statistics Dividends

Quarterly Annual

Cash from operating activities 22.99 M-13.54 M15.34 M38.8 M 56.03 M Cash from investing activities -283.76 M-116.44 M15.81 M22.96 M 21.44 M Cash from financing activities 273.37 M62.08 M-26.65 M-54.58 M -76.55 M Free cash flow 15.62 M-23.58 M7.98 M37.79 M 53.47 M

新闻

Bravura Solutions 2026财年上半年业绩：收入增长9.8%，上调全年指引

Bravura Solutions 1H26 presentation: Revenue up 9.8%, guidance upgraded

勇哥解决方案2026年上半年财报电话会议：收入增长成亮点

Earnings call transcript: Bravura Solutions’ H1 2026 highlights revenue growth

Bioventus Inc. (BVS) Presents at 44th Annual J.P. Morgan Healthcare Conference - Slideshow (NASDAQ:BVS) 2026-01-15

Bioventus Inc. (BVS) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

Bioventus Inc. (BVS) Presents at Piper Sandler 37th Annual Healthcare Conference - Slideshow (NASDAQ:BVS) 2025-12-04

Bioventus任命Ajay Dhankhar为Class II董事会成员

Bioventus appoints Ajay Dhankhar to board as Class II director

Bioventus 2025年第三季度报告：尽管收入持平，但有机增长8%且利润率扩大

Palantir, Uber among market cap stock movers on Tuesday

Bioventus Q3 2025 slides: 8% organic growth with margins expanding despite flat revenue